JP2023547889A5 - - Google Patents
Info
- Publication number
- JP2023547889A5 JP2023547889A5 JP2023525023A JP2023525023A JP2023547889A5 JP 2023547889 A5 JP2023547889 A5 JP 2023547889A5 JP 2023525023 A JP2023525023 A JP 2023525023A JP 2023525023 A JP2023525023 A JP 2023525023A JP 2023547889 A5 JP2023547889 A5 JP 2023547889A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid residues
- pharmaceutically acceptable
- acceptable salt
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063105678P | 2020-10-26 | 2020-10-26 | |
| US63/105,678 | 2020-10-26 | ||
| US202163193753P | 2021-05-27 | 2021-05-27 | |
| US63/193,753 | 2021-05-27 | ||
| PCT/US2021/047827 WO2022093374A1 (en) | 2020-10-26 | 2021-08-26 | Compounds,compositions and methods of use to treat spinal fusions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023547889A JP2023547889A (ja) | 2023-11-14 |
| JP2023547889A5 true JP2023547889A5 (enExample) | 2024-09-02 |
Family
ID=81383097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525023A Pending JP2023547889A (ja) | 2020-10-26 | 2021-08-26 | 脊椎融合を治療するための化合物、組成物、および使用の方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230390363A1 (enExample) |
| EP (1) | EP4232075A4 (enExample) |
| JP (1) | JP2023547889A (enExample) |
| AU (1) | AU2021369193A1 (enExample) |
| CA (1) | CA3196688A1 (enExample) |
| MX (1) | MX2023004829A (enExample) |
| WO (1) | WO2022093374A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3796941A4 (en) | 2018-05-30 | 2022-12-28 | Purdue Research Foundation | Targeting anabolic drugs for accelerated fracture repair |
| MX2023004796A (es) * | 2020-10-26 | 2023-07-18 | Purdue Research Foundation | Compuestos, composiciones y metodos de uso para tratar fracturas oseas. |
| WO2024246840A1 (en) * | 2023-06-01 | 2024-12-05 | Radius Health, Inc. | Methods for identification and quantitation of abaloparatide and related peptide impurities |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL266977B2 (en) * | 2016-11-30 | 2024-01-01 | Purdue Research Foundation | Fracture-targeted bone regeneration using thyroid hormone receptor stimulation |
| EP3765488A1 (en) * | 2018-03-12 | 2021-01-20 | Fresenius Kabi iPSUM S.r.l. | Process for the manufacture of pthrp analogue |
| EP3796941A4 (en) * | 2018-05-30 | 2022-12-28 | Purdue Research Foundation | Targeting anabolic drugs for accelerated fracture repair |
| MX2023004796A (es) * | 2020-10-26 | 2023-07-18 | Purdue Research Foundation | Compuestos, composiciones y metodos de uso para tratar fracturas oseas. |
-
2021
- 2021-08-26 EP EP21887114.3A patent/EP4232075A4/en active Pending
- 2021-08-26 CA CA3196688A patent/CA3196688A1/en active Pending
- 2021-08-26 WO PCT/US2021/047827 patent/WO2022093374A1/en not_active Ceased
- 2021-08-26 MX MX2023004829A patent/MX2023004829A/es unknown
- 2021-08-26 JP JP2023525023A patent/JP2023547889A/ja active Pending
- 2021-08-26 US US18/033,658 patent/US20230390363A1/en active Pending
- 2021-08-26 AU AU2021369193A patent/AU2021369193A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024506435A5 (enExample) | ||
| JP2023029957A (ja) | 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生 | |
| JP6223377B2 (ja) | 長期間作用性ペプチド類似体のための組成物 | |
| RU2242228C2 (ru) | Композиция для стимулирования роста | |
| JP5544169B2 (ja) | フェニルアルキルカルボン酸誘導体送達剤 | |
| ES2879947T3 (es) | Derivados de la tirosina y composiciones que los comprenden | |
| CN1185252C (zh) | 生长激素释放抑制因子肽类 | |
| JP2022514255A5 (enExample) | ||
| JP2010031018A5 (enExample) | ||
| JP2022517040A5 (enExample) | ||
| RU2011123700A (ru) | Нонапептид с противоопухолевой активностью | |
| RU2012121264A (ru) | Терапевтические пептиды | |
| JP2022512704A5 (enExample) | ||
| JP2024506435A (ja) | 化合物、組成物、および骨折を処置するための使用方法 | |
| JPWO2006118173A1 (ja) | 経皮吸収製剤 | |
| RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
| JP2004026678A (ja) | ２型糖尿病治療剤 | |
| JP2023547889A (ja) | 脊椎融合を治療するための化合物、組成物、および使用の方法 | |
| TW201106964A (en) | A motilin-link peptide compound offering absorptivity via mucous administration | |
| JP2002513764A5 (enExample) | ||
| CN1089950A (zh) | 新的结构改性的活性肠肽衍生物、其药物组合物及其治疗男性阳痿的应用 | |
| RU2003126176A (ru) | Кислотно-аддитивные соли тербинафина и яблочной кислоты | |
| CN104379161A (zh) | 促进血管生长的蛋白质及其用途 | |
| JP5173807B2 (ja) | 活性剤を送達するためのシクロプロピル化合物および組成物 | |
| JP5057628B2 (ja) | ポリペプチド・ドラッグ物質および他の難吸収性活性成分を含む組成物の経口および非経口投与後の薬理活性を強化させる組成物および方法 |